{"product_id":"european-association-of-dermato-oncology-11th-world-congress-of-melanoma-and-21st-eado-congress-2025","title":"European Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003ch3\u003eEuropean Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 100 videos + 1 pdf, size: 67.1 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"738\" data-start=\"320\"\u003eThe 11th World Congress of Melanoma combined with the 21st EADO Congress 2025 is a premier international event uniting specialists from around the globe to advance knowledge and practice in dermato-oncology. This congress offers a rich scientific program with plenary sessions, interactive symposia, workshops, and case-based learning covering every aspect of melanoma and skin cancer management.\u003c\/p\u003e\n\u003cp data-end=\"765\" data-start=\"740\"\u003e\u003cstrong data-end=\"763\" data-start=\"740\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1211\" data-start=\"766\"\u003e\n\u003cli data-end=\"869\" data-start=\"766\"\u003e\n\u003cp data-end=\"869\" data-start=\"768\"\u003eLatest advances in prevention, diagnosis, staging, and treatment of melanoma and other skin cancers\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"969\" data-start=\"870\"\u003e\n\u003cp data-end=\"969\" data-start=\"872\"\u003eInnovative surgical and non-surgical therapies, including immunotherapy and targeted treatments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1042\" data-start=\"970\"\u003e\n\u003cp data-end=\"1042\" data-start=\"972\"\u003eCase-based discussions focusing on complex and rare cutaneous tumors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1115\" data-start=\"1043\"\u003e\n\u003cp data-end=\"1115\" data-start=\"1045\"\u003eGross and microscopic pathology reviews presented by leading experts\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1211\" data-start=\"1116\"\u003e\n\u003cp data-end=\"1211\" data-start=\"1118\"\u003eAdvocacy and public health sessions addressing awareness, screening, and patient engagement\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1232\" data-start=\"1213\"\u003e\u003cstrong data-end=\"1230\" data-start=\"1213\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1404\" data-start=\"1233\"\u003e\n\u003cli data-end=\"1263\" data-start=\"1233\"\u003e\n\u003cp data-end=\"1263\" data-start=\"1235\"\u003e\u003cstrong data-end=\"1245\" data-start=\"1235\"\u003eDates:\u003c\/strong\u003e April 3–5, 2025\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1344\" data-start=\"1264\"\u003e\n\u003cp data-end=\"1344\" data-start=\"1266\"\u003e\u003cstrong data-end=\"1279\" data-start=\"1266\"\u003eLocation:\u003c\/strong\u003e Megaron Athens International Conference Centre, Athens, Greece\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1459\" data-start=\"1406\"\u003e\u003cstrong data-end=\"1427\" data-start=\"1406\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eThis congress is ideal for:\u003c\/p\u003e\n\u003cul data-end=\"1818\" data-start=\"1460\"\u003e\n\u003cli data-end=\"1547\" data-start=\"1460\"\u003e\n\u003cp data-end=\"1547\" data-start=\"1462\"\u003eDermatologists, oncologists, surgeons, and pathologists specializing in skin cancer\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1636\" data-start=\"1548\"\u003e\n\u003cp data-end=\"1636\" data-start=\"1550\"\u003eResearchers and clinicians seeking the latest scientific updates in dermato-oncology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1739\" data-start=\"1637\"\u003e\n\u003cp data-end=\"1739\" data-start=\"1639\"\u003eResidents and fellows aiming to expand their expertise and network with world leaders in the field\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1818\" data-start=\"1740\"\u003e\n\u003cp data-end=\"1818\" data-start=\"1742\"\u003eHealthcare advocates interested in advancing melanoma awareness and policy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1836\" data-start=\"1820\"\u003e\u003cstrong data-end=\"1834\" data-start=\"1820\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2173\" data-start=\"1837\"\u003e\n\u003cli data-end=\"1923\" data-start=\"1837\"\u003e\n\u003cp data-end=\"1923\" data-start=\"1839\"\u003eGain cutting-edge knowledge from international experts across multiple specialties\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1993\" data-start=\"1924\"\u003e\n\u003cp data-end=\"1993\" data-start=\"1926\"\u003eParticipate in highly interactive and practical learning sessions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2073\" data-start=\"1994\"\u003e\n\u003cp data-end=\"2073\" data-start=\"1996\"\u003eNetwork with peers and key opinion leaders in a dynamic, global environment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2173\" data-start=\"2074\"\u003e\n\u003cp data-end=\"2173\" data-start=\"2076\"\u003eExperience an inspiring educational program in one of Europe’s most historic and vibrant cities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCLOSING.mp4\u003cbr\u003eDERMOSCOPY CONTEST I.mp4\u003cbr\u003eDERMOSCOPY CONTEST II.mp4\u003cbr\u003eFinal_Programm_WCM2025_V5.pdf\u003cbr\u003eFREE COMMUNICATION I Melanoma – systemic therapy other than ICI therapy.mp4\u003cbr\u003eFREE COMMUNICATION II Squamous cell carcinoma + rare tumors.mp4\u003cbr\u003eFREE COMMUNICATION III Melanoma – Epidemiology and diagnostics.mp4\u003cbr\u003eFREE COMMUNICATION IV Melanoma – Experimental and translational studies.mp4\u003cbr\u003eFREE COMMUNICATION V Melanoma – Surgery.mp4\u003cbr\u003eFREE COMMUNICATION VI Basal cell carcinoma.mp4\u003cbr\u003eFREE COMMUNICATION VII Melanoma – Immune checkpint inhibitor (ICI) therapy.mp4\u003cbr\u003eKEYNOTE LECTURE KEY01 Skin cancer epidemic- is there light at the end of the tunnel.mp4\u003cbr\u003eKEYNOTE LECTURE KEY02 The journey from melanocytes to melanoma.mp4\u003cbr\u003eKEYNOTE LECTURE KEY03 Diagnostic tools for skin cancer detection beyond dermoscopy.mp4\u003cbr\u003eKEYNOTE LECTURE KEY04 New diagnostics, prognostic biomarkers and systemic therapy strategies sharply reduce the need for surgery in melanoma.mp4\u003cbr\u003eKEYNOTE LECTURE KEY05 Neoadjuvant therapy- a new standard of care for melanoma.mp4\u003cbr\u003eKEYNOTE LECTURE KEY06 Improving outcomes in melanoma beyond the standard use of immune checkpoint blockers.mp4\u003cbr\u003eKEYNOTE LECTURE KEY07 The future of non-melanoma skin cancer treatment.mp4\u003cbr\u003eOpening Ceremony.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT01 Platinum Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT02 Gold Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT03 Silver Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT04 Silver Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT05 Further Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT06 Further Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT07 Silver Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT08 Gold Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT09 Further Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT10 Platinum Sponsor.mp4\u003cbr\u003eSATELLITE SYMPOSIUM SAT11 Further Sponsor.mp4\u003cbr\u003eSOCRATES’ DIALOGUES I- AN INTERACTIVE MORNING SESSION The role of microbiome for immunotherapies.mp4\u003cbr\u003eSOCRATES’ DIALOGUES II- AN INTERACTIVE MORNING SESSION Treatment refractory stage IV melanomas- what do I do.mp4\u003cbr\u003eSOCRATES’ DIALOGUES III- AN INTERACTIVE MORNING SESSION Women in dermato-oncology.mp4\u003cbr\u003eSOCRATES’ DIALOGUES IV- AN INTERACTIVE MORNING SESSION Prognostic and predictive biomarkers for melanoma.mp4\u003cbr\u003eSOCRATES’ DIALOGUES V- AN INTERACTIVE MORNING SESSION Challenges in neoadjuvant therapy.mp4\u003cbr\u003eSOCRATES’ DIALOGUES VI- AN INTERACTIVE MORNING SESSION How to build up a career in dermato-oncology.mp4\u003cbr\u003eSYMPOSIUM SY01 Controversies – Skin cancer screening should be abandoned.mp4\u003cbr\u003eSYMPOSIUM SY02 Dermoscopy 1- Total body photography, digital dermoscopy and scanners- indications and procedures.mp4\u003cbr\u003eSYMPOSIUM SY03 Prognostic and predictive biomarkers in melanoma.mp4\u003cbr\u003eSYMPOSIUM SY04 Squamous cell carcinoma- epidemiology and management.mp4\u003cbr\u003eSYMPOSIUM SY05 Merkel cell carcinoma- epidemiology, surgery and radiology.mp4\u003cbr\u003eSYMPOSIUM SY06 Controversies – Does melanoma follow-up contribute to overall survival improvement.mp4\u003cbr\u003eSYMPOSIUM SY07 Basal cell carcinoma- epidemiology and management.mp4\u003cbr\u003eSYMPOSIUM SY08 Intralesional therapies of skin cancer.mp4\u003cbr\u003eSYMPOSIUM SY09 Liquid biopsy as a decision maker in melanoma.mp4\u003cbr\u003eSYMPOSIUM SY10 Melanoma classifications- past, present and future.mp4\u003cbr\u003eSYMPOSIUM SY11 Treatment of cutaneous lymphomas- what’s coming from the pipeline.mp4\u003cbr\u003eSYMPOSIUM SY12 Adoptive T-Cell transfer (TILs) for advanced melanomas.mp4\u003cbr\u003eSYMPOSIUM SY13 Interdisciplinary tumor board- challenging skin cancer cases I.mp4\u003cbr\u003eSYMPOSIUM SY14 Overdiagnosis of melanoma- a real problem.mp4\u003cbr\u003eSYMPOSIUM SY15 Neoadjuvant treatment of melanoma.mp4\u003cbr\u003eSYMPOSIUM SY16 Melanoma guidelines around the world.mp4\u003cbr\u003eSYMPOSIUM SY17 Immunotherapy of Merkel cell carcinoma.mp4\u003cbr\u003eSYMPOSIUM SY18 Primary ocular melanoma- genetics, clinical appearance and treatment.mp4\u003cbr\u003eSYMPOSIUM SY19 Artificial Intelligence in dermato-oncology.mp4\u003cbr\u003eSYMPOSIUM SY20 Registries for real world treatment data and outcome research.mp4\u003cbr\u003eSYMPOSIUM SY21 Memorial Symposium for Jeff Weber Drug resistance to immune checkpoint inhibition.mp4\u003cbr\u003eSYMPOSIUM SY22 Skin Care in Organ Transplant Patients Europe (SCOPE).mp4\u003cbr\u003eSYMPOSIUM SY23 Melanoma research.mp4\u003cbr\u003eSYMPOSIUM SY24 Congenital nevi- risk and management.mp4\u003cbr\u003eSYMPOSIUM SY25 Management of mucosal melanoma.mp4\u003cbr\u003eSYMPOSIUM SY26 Microbiome in cancer- more than gut feelings.mp4\u003cbr\u003eSYMPOSIUM SY27 Controversies – Is there a future for sentinel node biopsy.mp4\u003cbr\u003eSYMPOSIUM SY28 Drug resistance to targeted therapies.mp4\u003cbr\u003eSYMPOSIUM SY29 Molecular tumor board for skin cancers.mp4\u003cbr\u003eSYMPOSIUM SY30 Treatment of field cancerization including actinic cheilitis.mp4\u003cbr\u003eSYMPOSIUM SY31 Adjuvant treatment of melanoma.mp4\u003cbr\u003eSYMPOSIUM SY32 Management of brain metastasis.mp4\u003cbr\u003eSYMPOSIUM SY33 Radiotherapy for melanoma and other skin cancers- where are we now.mp4\u003cbr\u003eSYMPOSIUM SY34 Surgical pearls in the treatment of skin cancer.mp4\u003cbr\u003eSYMPOSIUM SY35 Rare skin tumors (adnexal, sebaceous, DFSP).mp4\u003cbr\u003eSYMPOSIUM SY36 Global epidemiologic trends and survival in skin cancer.mp4\u003cbr\u003eSYMPOSIUM SY37 High-risk melanocytic nevi- are they existing, and how to define what to do.mp4\u003cbr\u003eSYMPOSIUM SY38 Drug access across the world- approval is not reimbursement.mp4\u003cbr\u003eSYMPOSIUM SY39 Occupational skin cancer- The sleeping giant (4th Multi-stakeholder summit).mp4\u003cbr\u003eSYMPOSIUM SY40 Skin cancer on colored skin- clinical appearance and treatment.mp4\u003cbr\u003eSYMPOSIUM SY41 Mohs micrographic surgery and skin cancer management.mp4\u003cbr\u003eSYMPOSIUM SY42 Immune checkpoint inhibition for non-melanoma skin cancer.mp4\u003cbr\u003eSYMPOSIUM SY43 Immunotherapies of metastatic ocular melanoma in first- and second line.mp4\u003cbr\u003eSYMPOSIUM SY44 Cutaneous sarcomas- diagnosis and treatment.mp4\u003cbr\u003eSYMPOSIUM SY45 Primary prevention of skin cancer.mp4\u003cbr\u003eSYMPOSIUM SY46 Is there a future for sentinel node biopsy.mp4\u003cbr\u003eSYMPOSIUM SY47 Patient Advocacy Groups.mp4\u003cbr\u003eSYMPOSIUM SY48 Interdisciplinary tumor board- challenging skin cancer cases II.mp4\u003cbr\u003eSYMPOSIUM SY49 New devices for ..mp4\u003cbr\u003eSYMPOSIUM SY50 Management of adverse events in immuno-oncology.mp4\u003cbr\u003eSYMPOSIUM SY51 Promising agents for PD1-refractory patients.mp4\u003cbr\u003eSYMPOSIUM SY52 Melanoma pathology – genomics and morphology.mp4\u003cbr\u003eSYMPOSIUM SY53 Treatment at the end of the life.mp4\u003cbr\u003eSYMPOSIUM SY54 Management of adverse events in targeted therapies.mp4\u003cbr\u003eSYMPOSIUM SY55 Management of lentigo maligna and acral lentiginous melanomas.mp4\u003cbr\u003eSYMPOSIUM SY56 Immune checkpoint inhibition in immunocompromised patients.mp4\u003cbr\u003eSYMPOSIUM SY57 Melanocytic lesions of unknown potential- biology, prognosis, treatment and follow-up.mp4\u003cbr\u003eSYMPOSIUM SY58 Dermoscopy 2- Dermoscopy in melanoma management.mp4\u003cbr\u003eSYMPOSIUM SY59 Actinic keratosis- current treatment and future perspectives.mp4\u003cbr\u003eSYMPOSIUM SY60 Diagnosis and management of cutaneous T-and B-cell lymphomas.mp4\u003cbr\u003eSYMPOSIUM SY61 Interdisciplinary tumor board- challenging skin cancer cases III.mp4\u003cbr\u003eSYMPOSIUM SY62 Dermoscopy 3- Difficult clinical scenarios.mp4\u003cbr\u003eSYMPOSIUM SY63 Surgery of stage IV melanoma- still needed.mp4\u003cbr\u003eSYMPOSIUM SY64 Current primary staging and follow-up recommendations for melanoma patients.mp4\u003cbr\u003eSYMPOSIUM SY65 Genetic susceptibility of melanoma and cancer syndromes.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954500931682,"sku":"MED-AMB04740","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/European-Association-of-Dermato-Oncology-11th-World-Congress-of-Melanoma-and-21st-EADO-Congress-2025.jpg?v=1779378208","url":"https:\/\/meducourse.com\/products\/european-association-of-dermato-oncology-11th-world-congress-of-melanoma-and-21st-eado-congress-2025","provider":"Meducourse","version":"1.0","type":"link"}